S troke-survivors are at particular risk of cognitive decline. Three month dementia prevalence is ≥30%, and even minor stroke events have cognitive sequel.1,2 Poststroke cognitive impairment is associated with increased mortality, disability, and institutionalization. 3 The importance of cognitive change is highlighted by stroke-survivors themselves. In a national priority setting exercise, cognitive impairment was voted the single most important topic for stroke research. 4 A first step in management of cognitive problems is recognition and diagnosis. Informal clinician assessment will miss important cognitive problems, 5 and formal cognitive testing is recommended. [6][7][8] The ideal would be expert, multidisciplinary assessment informed by comprehensive investigations. This approach is not feasible at a population level. In practice, a 2-step system is adopted, with baseline cognitive testing used for screening or triage and specialist assessment to define the cognitive problem offered depending on the results.Although there is general agreement on the merits of poststroke cognitive assessment, there is no consensus on a preferred testing strategy. [6][7][8] Various cognitive screening tools are available with substantial variation in test used. 9,10 The clinical meaning of cognitive problems after stroke will vary according to test context. Cognitive impairment diagnosed in the first days post stroke may reflect a mix of delirium, strokespecific impairments, and prestroke cognitive decline. 2,11,12 In the longer term, assessments aim to make or refute a dementia diagnosis. Common to all test situations is a final diagnosis of presence/absence of clinically important impairments. A screening assessment should detect this clinical syndrome of all-cause, poststroke multidomain cognitive impairment.Background and Purpose-Guidelines recommend screening stroke-survivors for cognitive impairments. We sought to collate published data on test accuracy of cognitive screening tools. Methods-Index test was any direct, cognitive screening assessment compared against reference standard diagnosis of (undifferentiated) multidomain cognitive impairment/dementia. We used a sensitive search statement to search multiple, crossdisciplinary databases from inception to January 2014. Titles, abstracts, and articles were screened by independent researchers. We described risk of bias using Quality Assessment of Diagnostic Accuracy Studies tool and reporting quality using Standards for Reporting of Diagnostic Accuracy guidance. Where data allowed, we pooled test accuracy using bivariate methods. Results-From 19 182 titles, we reviewed 241 articles, 35 suitable for inclusion. There was substantial heterogeneity: 25 differing screening tests; differing stroke settings (acute stroke, n=11 articles), and reference standards used (neuropsychological battery, n=21 articles). One article was graded low risk of bias; common issues were case-control methodology (n=7 articles) and missing data (n=22
Lees et al Cognitive Screening in S...